Publications

Journal Article
Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.
Ppublish 182 citations
Electronic publication date
May 26, 1999

View on Pubmed.gov 10339595 | View on doi.org 10.1073/pnas.96...

Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFkappaB.

Search for publications in this journal Proc Natl Acad Sci U S A - 96(11):6377-81

Abstract

The antiinflammatory action of aspirin generally has been attributed to direct inhibition of cyclooxygenases (COX-1 and COX-2), but additional mechanisms are likely at work. These include aspirin's inhibition of NFkappaB translocation to the nucleus as well as the capacity of salicylates to uncouple oxidative phosphorylation (i.e., deplete ATP). At clinically relevant doses, salicylates cause cells to release micromolar concentrations of adenosine, which serves as an endogenous ligand for at least four different types of well-characterized receptors. Previously, we have shown that adenosine mediates the antiinflammatory effects of other potent and widely used antiinflammatory agents, methotrexate and sulfasalazine, both in vitro and in vivo. To determine in vivo whether clinically relevant levels of salicylate act via adenosine, via NFkappaB, or via the "inflammatory" cyclooxygenase COX-2, we studied acute inflammation in the generic murine air-pouch model by using wild-type mice and mice rendered deficient in either COX-2 or p105, the precursor of p50, one of the components of the multimeric transcription factor NFkappaB. Here, we show that the antiinflammatory effects of aspirin and sodium salicylate, but not glucocorticoids, are largely mediated by the antiinflammatory autacoid adenosine independently of inhibition of prostaglandin synthesis by COX-1 or COX-2 or of the presence of p105. Indeed, both inflammation and the antiinflammatory effects of aspirin and sodium salicylate were independent of the levels of prostaglandins at the inflammatory site. These experiments also provide in vivo confirmation that the antiinflammatory effects of glucocorticoids depend, in part, on the p105 component of NFkappaB.

References

Inflammation. 1994 Jun;18(3):323-35

Science. 1995 Oct 13;270(5234):283-6

Biochem Pharmacol. 1994 Feb 9;47(3):563-72

Biochem J. 1983 Aug 15;214(2):317-23

Cited by 182 citations (total)

Journal Article Research Support, Non-U.S. Gov't

Differential direct effects of cyclo-oxygenase-1/2 inhibition on proteoglycan turnover of human osteoarthritic cartilage: an in vitro study.

Electronic publication date January 30, 2007

Search for publications in this journal Arthritis Res Ther

Simon C Mastbergen [...] Floris P J G Lafeber et al.

Treatment of osteoarthritis (OA) with nonsteroidal anti-inflammatory drugs (NSAIDs) diminishes inflammation along with mediators of cartilage destruction. However, NSAIDs may...

Journal Article Research Support, Non-U.S. Gov't Review

Something old, something new and something very old: drugs for treating type 2 diabetes.

Electronic publication date January 20, 2015

Search for publications in this journal Br J Pharmacol

D Kaiser [...] E Oetjen et al.

Diabetes mellitus belongs to the most rapidly increasing diseases worldwide. Approximately 90-95% of these patients suffer from type 2 diabetes...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Substances